NCT00098956View on ClinicalTrials.gov

7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
Interventions
DRUG

topotecan hydrochloride

Given IV

DRUG

7-hydroxystaurosporine

Given IV

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital Phase 2 Consortium, Toronto

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00098956 - 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter